BIOLASE, Inc to Report First Quarter 2021 Results on May 13, 2021

Rhea-AI Summary

BIOLASE, a leader in dental lasers, announced it will release its first quarter 2021 financial results on May 13, 2021, after market close. A conference call will follow at 4:30 p.m. ET for discussing results and corporate developments. The call can be accessed via dial-in numbers for U.S./Canada and international participants. BIOLASE's laser systems enhance dental procedures, with over 41,200 systems sold in more than 80 countries. An audio archive will be available for 30 days post-call.

FOOTHILL RANCH, Calif., May 6, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2021 financial and operating results on Thursday, May 13, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 353-6461. For international participants outside the U.S./Canada, the dial-in number is  (334) 323-0501. For all callers, refer to the Conference ID 5287389. To access the live webcast, go to BIOLASE Investor Events Page.

An audio archive of the webcast will be available for 30 days on the Investors section of the BIOLASE website.

About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus^®, Waterlase Express^™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE^®, Waterlase^® and Waterlase iPlus^® are registered trademarks of BIOLASE, Inc.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-inc-to-report-first-quarter-2021-results-on-may-13-2021-301286021.html

SOURCE BIOLASE, Inc.

FAQ

When will BIOLASE announce its first quarter 2021 financial results?

BIOLASE will announce its first quarter 2021 financial results on May 13, 2021.

What time is the BIOLASE conference call on May 13, 2021?

The BIOLASE conference call on May 13, 2021, will take place at 4:30 p.m. ET.

How can I access the BIOLASE conference call?

You can access the BIOLASE conference call via dial-in numbers for U.S./Canada and international participants.

Where can I find the archive of the BIOLASE conference call?

The audio archive of the BIOLASE conference call will be available for 30 days on the Investors section of the BIOLASE website.

What is the significance of the BIOLASE product offerings?

BIOLASE's laser products advance dental procedures, providing superior performance with less pain and quicker recovery.